ADHD in children and adolescents
- PMID:19445793
- PMCID: PMC2907929
ADHD in children and adolescents
Abstract
Introduction: Prevalence estimates of attention deficit hyperactivity disorder (ADHD) vary according to the diagnostic criteria used and the population sampled. DSM-IV prevalence estimates among school children in the US are 3-5%, but other estimates vary from 1.7% to 16.0%. No objective test exists to confirm the diagnosis of ADHD, which remains a clinical diagnosis. Other conditions frequently co-exist with ADHD.
Methods and outcomes: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of pharmacological treatments for ADHD in children and adolescents? What are the effects of psychological treatments for ADHD in children and adolescents? What are the effects of combination treatments for ADHD in children and adolescents? We searched: Medline, Embase, The Cochrane Library, and other important databases up to June 2007 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
Results: We found 34 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
Conclusions: In this systematic review we present information relating to the effectiveness and safety of the following interventions: atomoxetine, bupropion, clonidine, dexamfetamine sulphate, homeopathy, methylphenidate, modafinil, omega 3-polyunsaturated fatty acids, and psychological/behavioural treatment (either alone or in combination with a drug treatment).
Similar articles
- ADHD in children and adolescents.Keen D, Hadijikoumi I.Keen D, et al.BMJ Clin Evid. 2011 Feb 4;2011:0312.BMJ Clin Evid. 2011.PMID:21718557Free PMC article.Review.
- Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.Osland ST, Steeves TD, Pringsheim T.Osland ST, et al.Cochrane Database Syst Rev. 2018 Jun 26;6(6):CD007990. doi: 10.1002/14651858.CD007990.pub3.Cochrane Database Syst Rev. 2018.PMID:29944175Free PMC article.Review.
- Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.Gillies D, Leach MJ, Perez Algorta G.Gillies D, et al.Cochrane Database Syst Rev. 2023 Apr 14;4(4):CD007986. doi: 10.1002/14651858.CD007986.pub3.Cochrane Database Syst Rev. 2023.PMID:37058600Free PMC article.Review.
- Systematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetine.Roskell NS, Setyawan J, Zimovetz EA, Hodgkins P.Roskell NS, et al.Curr Med Res Opin. 2014 Aug;30(8):1673-85. doi: 10.1185/03007995.2014.904772. Epub 2014 Apr 15.Curr Med Res Opin. 2014.PMID:24627974Review.
- A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, Golder S, Taylor E, Drummond M, Riemsma R.King S, et al.Health Technol Assess. 2006 Jul;10(23):iii-iv, xiii-146. doi: 10.3310/hta10230.Health Technol Assess. 2006.PMID:16796929Review.
Cited by
- Study of the Vertical Structure of the Coastal Boundary Layer Integrating Surface Measurements and Ground-Based Remote Sensing.Lo Feudo T, Calidonna CR, Avolio E, Sempreviva AM.Lo Feudo T, et al.Sensors (Basel). 2020 Nov 14;20(22):6516. doi: 10.3390/s20226516.Sensors (Basel). 2020.PMID:33202664Free PMC article.
- Safety and efficacy of clonidine and clonidine extended-release in the treatment of children and adolescents with attention deficit and hyperactivity disorders.Ming X, Mulvey M, Mohanty S, Patel V.Ming X, et al.Adolesc Health Med Ther. 2011 Sep 30;2:105-12. doi: 10.2147/AHMT.S15672. eCollection 2011.Adolesc Health Med Ther. 2011.PMID:24600280Free PMC article.Review.
References
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV), 4th ed. Washington, DC: American Psychiatric Association, 1994.
- World Health Organization. International statistical classification of diseases and related health problems, 10th rev ed. Geneva: World Health Organization, 1994.
- Taylor E, Sergeant J, Doepfner M, et al. Clinical guidelines for hyperkinetic disorder. European Society for Child and Adolescent Psychiatry. Eur Child Adolesc Psychiatry 1998;7:184–200. - PubMed
- Faraone SV, Spencer T, Aleardi M, et al. Meta-Analysis of the Efficacy of Methylphenidate for Treating Adult Attention-Deficit/Hyperactivity Disorder. J Clin Psychopharmacol 2004;24:24–29. - PubMed
- Goldman LS, Genel M, Bezman RJ, et al. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA 1998;279:1100–1107. - PubMed
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous